Introduction
The rostral part of the rostral ventrolateral medulla (RVLM) is a key nucleus containing bulbospinal neurons that are inhibited by baroreceptor activation (presympathetic neurons), and provide a monosynaptic excitatory drive to preganglionic sympathetic neurons in the intermediolateral cell column of the spinal cord (Oshima et al., 2006; Oshima et al., 2008) .
Overall sympathetic outflow is largely determined by the balance of excitatory and inhibitory inputs to the presympathetic neurons in the RVLM (Dampney, 1994; Pilowsky and Goodchild, 2002) . The inputs that affect the activity of RVLM neurons may arise from other parts of the brain and spinal cord, or from afferent neurons in the periphery. At the present time, a complete understanding of the source of these different inputs, the neurotransmitters that they use, and their postsynaptic receptors is not known.
Neuromedin U (NMU), originally isolated from porcine spinal cord, is so named because of its potent contractile activity on uterine smooth muscle (Minamino et al., 1985) . The Nterminal region of NMU varies greatly from species to species (mammals to amphibians), but the C-terminal sequence is highly conserved and is the biologically active part of the molecule. NMU acts equally at two G-protein coupled receptors (G q/11 and to a lesser extent G i/0 ), NMU receptor 1 (NMU1) and NMU receptor 2 (NMU2) (Brighton et al., 2004; Gartlon et al., 2004) . NMU1 and NMU2 are located predominantly, but not exclusively, in peripheral tissues and the central nervous system (CNS), respectively (Howard et al., 2000; Raddatz et al., 2000; Szekeres et al., 2000; Westfall et al., 2002) . NMU injection into brain decreases food intake and body weight gain (Howard et al., 2000; Nakazato et al., 2000; Peier et al., 2009 ), increases release of oxytocin, arginine vasopressin and ACTH (Ozaki et al., 2002; Rokkaku et al., 2003) , increases gross locomotor activity and body temperature (Howard et This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on January 18, 2012 as DOI: 10.1124/jpet.111.191254 at ASPET Journals on October 26, 2017 jpet.aspetjournals.org Downloaded from JPET #191254 6 al., 2000; Nakazato et al., 2000) and induces stress (Hanada et al., 2001; Zeng et al., 2006) and pain (Yu et al., 2003; Nakahara et al., 2004b; Zeng et al., 2006) , suggesting differential physiological and pharmacological roles of NMU.
Neurons expressing NMU are present in the key cardiorespiratory areas of the brainstem and spinal cord including the nucleus tractus solitarius (NTS), dorsal motor nucleus of the vagus, inferior olive and area postrema (Howard et al., 2000) , raising the possibility that NMU may participate in the central regulation of cardiorespiratory function. NMU2 are expressed predominantly in paraventricular nucleus, the wall of 3 rd ventricle, hippocampus, dorsal root ganglia and dorsal horn of spinal cord (Howard et al., 2000) . Intracerebroventricular injection of NMU increases sympathetic nerve activity (SNA), blood pressure (BP), heart rate (HR) and plasma noradrenaline (Chu et al., 2002; Tanida et al., 2009 ). Microinjection of NMU into the NTS decreases BP and HR (Tsubota et al., 2003) . We have previously demonstrated that NMU in the spinal cord shows differential effect on sympathetic outflow, respiration and sympathetic reflexes (Rahman et al., 2011) . To date, no study has examined the effects of NMU in the RVLM on cardiorespiratory function and sympathetic reflexes.
The objective of the present study was 1) to determine the cardiovascular and respiratory effects elicited by microinjection of NMU into the RVLM of anaesthetized rats, and 2) to evaluate the effects of NMU on somatosympathetic, baro-and chemo-reflexes in the RVLM.
Our principal findings are that bilateral microinjection of NMU in the RVLM increases mean arterial pressure (MAP), HR, splanchnic SNA (SSNA), lumbar SNA (LSNA) at lower doses, but shows biphasic effect at higher dose. NMU in the RVLM increases respiratory drive.
NMU also attenuates somatosympathetic, and peripheral and central chemoreceptor reflexes.
This article has not been copyedited and formatted. The final version may differ from this version. nerve activity (PNA). Through a retroperitoneal approach, the left greater splanchnic and lumbar nerves were isolated and dissected; the left phrenic nerve was approached dorsally.
The distal end of the nerves were tied with 5/0 silk thread and cut to permit recording of efferent nerve activity. In some experiments, the sciatic nerve was isolated, tied and cut. Once the nerves were isolated, they were covered with saline soaked cotton wool for the duration of the remainder of surgical preparation to prevent desiccation.
Rats were placed in a stereotaxic frame and the head tilted downwards at a 45 0 angle to the horizontal. All animals were paralyzed (pancuronium bromide; 0.8 mg iv initially, then 0.4 mg/h iv) and artificially ventilated with oxygen-enriched room air. A bilateral vagotomy was performed to ensure the phrenic nerve discharge was not synchronized to the cycle of mechanical ventilation. End-tidal CO 2 and pH were maintained at 4.0-4.5% and 7.35-7.45, respectively, by adjusting the rate and depth of ventilation after arterial blood gas analysis (pH 7.4 ± 0.02, PaCO 2 40.5 ± 0.4). Animals were infused with 5% glucose in water (1.0-2.0 ml/h) to ensure hydration. Nerve recordings were made with bipolar silver wire electrodes.
The recording electrodes were immersed in a pool of liquid paraffin oil to prevent dehydration and for electrical insulation. After nerves were placed on the recording electrodes, rats were allowed to stabilize for 30-60 min. The neurograms were amplified (x10,000; CWE Inc., Ardmore, PA, USA), band pass filtered (0.1-2 kHz), sampled at 3 kHz (1401 plus, CED Ltd, Cambridge, UK) and recorded on computer using Spike2 software (v7, CED Ltd, Cambridge, UK).
The dorsal surface of the medulla was exposed by partial occipital craniotomy. The dura was cut and reflected laterally and the nerve tissue was kept moist by physiological saline until This article has not been copyedited and formatted. The final version may differ from this version. the experiment protocol began. Brain microinjections and, functional identification of the RVLM, was performed as described previously (Rahman et al., 2012; Shahid et al., 2011b) .
Briefly, bilateral microinjection of test agents into the RVLM, at a fixed volume of 50 nl, was carried out stereotaxically and sequentially with single-or multi-barrel glass pipettes over a 10-s period. At the beginning of each experiment, RVLM was identified functionally on either side by an increase of >30 mmHg in MAP following microinjection of L-glutamic acid (5 nmol). The preliminary coordinates used to find the RVLM were 1.8 mm rostro-caudal, 1.8 mm medio-lateral, and 3.5 mm dorso-ventral to calamus scriptorius. Vehicle solutions (PBS) contained 2% rhodamine beads to aid in subsequent histological verification of the injection site. The brains were then removed from the skulls, fixed in 4% paraformaldehyde and sectioned at 50 µm to verify the microinjection sites. Only rats with microinjection sites within the boundaries of the RVLM were used for data analysis.
Activation of sympathetic reflexes
Reflexes were evoked as described previously (Rahman et al., 2011; Shahid et al., 2011a; Shahid et al., 2011b 
Experimental protocol
This article has not been copyedited and formatted. The final version may differ from this version. The following sympathetic reflexes were evoked before and after bilateral microinjection of vehicle or NMU (100 pmol), respectively: (i) somatosympathetic reflex; (ii) baroreflex; (iii) peripheral chemoreceptor reflex; and (iv) central chemoreflex. One reflex was conducted in a single rat. Each reflex was evoked at both the peak excitatory and inhibitory phases of NMU response.
Data acquisition and analysis
For averaging purpose, neurograms were rectified and smoothed (SSNA and LSNA, 1 s time constant; PNA, 50 ms). Zero SNA value was obtained from the minimum background activity after death and was subtracted from SNA before analysis with off-line software To analyse the data from the baroreflex function tests, mean MAP was divided into 1 s consecutive bins and the average SSNA/LSNA during each bin was determined; successive values were tabulated and graphed as XY plots, taking MAP as the abscissa and SSNA/LSNA as the ordinate. Each data set was then analysed to determine the sigmoidal curve of best fit (Kent et al., 1972) , which is described by Eq 2.
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where y is SSNA or LSNA, x is MAP, A1 is the y range (y at the top plateau -y at the bottom plateau), A2 is the gain coefficient, A3 is the value of x at the midpoint (which is also the point of maximum gain), and A4 is y at the bottom plateau. The computed baroreflex function curves were differentiated to determine the gain of SNA of the baroreflex across the full range of MAP and the peak gain of each curve was determined. The range of SNA was calculated as the difference between the values at the upper and lower plateaus of the curve.
The threshold and saturation values for MAP were defined (McDowall and Dampney, 2006) as the values of MAP at which y was 5% (of the y range) below and above the upper and lower plateaus, respectively.
Statistical analysis was conducted with GraphPad Prism (version 5.0) (GraphPad, La Jolla, CA, USA). Grouped data are expressed as mean ± SE. Paired t-test was used to analyze peak effects and reflexes. P < 0.05 was considered significant. Urethane, L-glutamic acid, glucose, PE and SNP were purchased from Sigma-Aldrich (NSW, Australia), pancuronium bromide from AstraZeneca Pty Ltd (NSW, Australia), rhodamine microbeads from Molecular Probes (NSW, Australia) and PBS (10 mM in 0.9% NaCl) tablets from AMRESCO Inc. (Solon, OH, USA). NMU and rhodamine (2% v/v) were dissolved and further diluted in PBS (10 mM; pH 7.4). PBS, PE and SNP were prepared in de-ionised water. Urethane was dissolved in 0.9% NaCl and L-glutamic acid in PBS.
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Results

Cardiorespiratory responses to microinjection of NMU into the RVLM
To determine the effect of NMU in the RVLM on the MAP, HR, SSNA and LSNA, NMU was microinjected bilaterally at three different doses (25, 50 and 100 pmol) into the functionally identified and histologically verified sites within the RVLM. In the anaesthetized rat, baseline MAP and HR were 99 ± 7 mmHg and 496 ± 5 bpm, (n = 16) respectively.
Microinjection of NMU into the RVLM elicited a dose-dependent excitatory response on the cardiovascular parameters recorded ( Figure 1A , B). At lower doses (25 and 50 pmol, n = 4 and 6), NMU increased MAP, HR, SSNA and LSNA ( Figure 1B ). Higher dose of NMU (100 pmol, n = 6) promoted a short hypertensive, tachycardiac and sympathoexcitatory response followed by a prolonged hypotensive, bradycardiac and sympathoinhibitory response ( Figure   1A ). The duration of the excitatory response to NMU was similar at lower and higher doses but the magnitude of the response was greater at higher doses. The maximum response was observed at 100 pmol injection of NMU with an increase in MAP, HR, SSNA and LSNA of JPET #191254
1 5 (P<0.001), respectively; and a decrease of 33 ± 3 mmHg (P<0.001), 25 ± 4 bpm (P<0.01), 42 ± 5 % (P<0.001) and 52 ± 7 % (P<0.01), respectively, as compared to PBS ( Figure 1B ). The effects were almost immediate and peaked about 30 seconds after bilateral administration of the peptide ( Figure 1A ). The excitatory response lasted for 5-7 min when the inhibitory response started that returned to baseline in about 30 min ( Figure 1A ). The 100 pmol dose of NMU was used for the reflex studies. Microscopic examination of microinjection sites, marked with rhodamine microbeads, confirmed that all injections used in this study were within 500 µm of the caudal end of the facial nucleus ( Figure 1C ). Figure 2A , B).
Effect of NMU on SNA-respiration related rhythm in the RVLM
Peri-phrenic averaging of the sympathetic nerve activity produces inspiratory (I) and postinspiratory (PI) peaks in SSNA ( Figure 3A ). On the other hand, LSNA showed only one distinct respiratory-related peak during PI-period ( Figure 3C ), consistent with our previous report (Miyawaki et al., 2002) . However, we measured the AUC of the area in LSNA corresponding to the I-period. At the excitatory phase of NMU (100 pmol), the AUC of Ipeak of both SSNA and LSNA was increased by 42 ± 11 % (n = 4, P<0.05) and 37 ± 9 % (n = 4, P<0.05), respectively as compared to control whereas the AUC of PI-peak of both SSNA and LSNA were decreased significantly by 47 ± 7 % (n = 4, P<0.01) and 46 ± 7 % (n = 4, This article has not been copyedited and formatted. The final version may differ from this version. P<0.01), respectively, as compared to control ( Figure 3A-D) . During the inhibitory phase of NMU (100 pmol) response, the AUC of both the I-and PI-peaks of SSNA and LSNA were significantly reduced (SSNA: 42 ± 9 % and 59 ± 10 % respectively, n = 4, P<0.01; LSNA: 59 ± 14 % and 65 ± 14 % respectively, n = 4, P<0.05) as compared to control (100%) ( Figure   3A -D).
Effect of NMU injection into the RVLM on somatosympathetic reflex
To investigate whether NMU injection into the RVLM altered the integration of somatosympathetic reflex as represented by two characteristic excitatory peaks in SSNA and LSNA, sciatic nerve was stimulated intermittently at baseline (control) and after PBS and NMU (100 pmol) injection ( Figure 4A ,C). The latencies of the peaks of SSNA (91 ± 2 and 181 ± 3 ms, respectively; n = 6) or LSNA (112 ± 3 and 201 ± 6 ms, respectively; n = 6) were not significantly altered by PBS (SSNA: 91 ± 1 and 181 ± 3 ms, respectively; LSNA: 110 ± 3 and 198 ± 7 ms, respectively; n = 6) or NMU (SSNA: 95 ± 3 and 183 ± 5 ms, respectively, at excitatory phase and 88 ± 2 and 175 ± 5 ms, respectively, at inhibitory phase; LSNA: 114 ± 3 and 196 ± 5 ms, respectively, at excitatory phase and 118 ± 9 and 200 ± 11 ms, respectively, at inhibitory phase; n = 6) injection. The AUC of both the excitatory peaks of both SSNA and LSNA were significantly reduced at excitatory (SSNA: 62 ± 5 %, P<0.001, and 52 ± 7 %, P<0.01, respectively, n = 6; LSNA: 60 ± 6 % and 54 ± 10 %, respectively, n = 6, P<0.01; as compared to control (100%)) and inhibitory phase (SSNA: 47 ± 8 %, P<0.01, and 43 ± 7 %, P<0.001, respectively, n = 6; LSNA: 54 ± 4 % , P<0.001, and 51 ± 12 %, P<0.05, respectively, n = 6; as compared to control (100%)) of NMU (100 pmol) following bilateral microinjection in the RVLM (Figure 4A-D) .
Effect of NMU injection into the RVLM on baroreflex
Increase in systemic blood pressure following i.v. injection of PE activated arterial baroreceptors that elicited reflex sympathoinhibitory response in SSNA and LSNA ( Figure   5A ). The HR component of the baroreflex was not assessed because the rats were vagotomized. For SSNA, NMU (100 pmol) at its excitatory phase in the RVLM significantly increased the lower plateau, upper plateau, range of SSNA and maximum gain but reduced the operating range significantly as compared to control (n = 4, Figure 5B , Table 1 ) thereby increasing the barosensitivity. NMU (100 pmol) at its inhibitory phase, on the other hand, did not cause any significant alteration in any of the parameters of baroreflex function curve as compared to control (n = 4, Figure 5B , Table 1 ). For LSNA, at the excitatory phase of NMU (100 pmol) response in the RVLM, the threshold level and maximum gain of baroreflex function curve were significantly reduced whereas the upper plateau, saturation level and operating range were increased significantly as compared to control (n = 5, Figure 5C , Table   1 ). At the inhibitory phase, NMU increased the saturation level and operating range and decreased maximum gain without any significant change in other parameters (n = 5, Figure   5C , Table 1 ).
Effect of NMU injection into the RVLM on chemoreflex
Brief hypoxia (100% N 2 for 12-14 s) in rat activated peripheral chemoreceptors and resulted in sharp and brief increase in MAP, HR, SSNA, LSNA, PNamp and PNf ( Figure 6A ). NMU (100 pmol), at both excitatory and inhibitory phases, in the RVLM significantly reduced the effects of hypoxia on MAP (65 ± 8 and 67 ± 9 %, respectively, n = 5, P<0.05), HR (70 ± 9 and 79 ± 6 %, respectively, n = 5, P<0.05), SSNA (72 ± 2 %, P<0.001, and 77 ± 8 %,
P<0
.05, respectively, n = 5), LSNA (60 ± 10 and 54 ± 9 % respectively, n = 5, P<0.05) and This article has not been copyedited and formatted. The final version may differ from this version. PNf (66 ± 5 %, P<0.01, and 64 ± 9 %, P<0.05, respectively, n = 5) as compared to control (100%), without altering PNamp response ( Figure 6A ,B).
Hypercapnia (10% CO 2 for 1 min) in rat activated central chemoreceptors that elicited an increase in MAP, HR, SSNA, LSNA and PNamp ( Figure 7A ). NMU (100 pmol), at both excitatory and inhibitory phases, in the RVLM significantly reduced the effects of hypercapnia on MAP (33 ± 11 and 45 ± 6 %, respectively, n = 4, P<0.01), SSNA (64 ± 5 and 40 ± 5 %, respectively, n = 4, P<0.01), LSNA (63 ± 9 %, P<0.05, and 49 ± 8 %, P<0.01, respectively, n = 4) and PNamp (60 ± 5, and 47 ± 9 %, respectively, P<0.01, n = 4) but increased tachycardiac response (146 ± 11 and 151 ± 14 %, respectively, n = 4, P<0.05), as compared to control (100%) ( Figure 7A ,B).
Discussion
The novel findings of the study are 1) NMU microinjection into the RVLM causes sympathoexcitation, hypertension and tachycardia at lower doses, while at a higher dose, controversial. Agonist binding to NMU1 and NMU2 is reported to activate both G q/11 and G i/0 (Brighton et al., 2004; Brighton et al., 2008) . By contrast, other studies suggest that 1) NMU1
and NMU2 couple only to G q/11 (Raddatz et al., 2000; Shan et al., 2000) or 2) activation of NMU2 increases neuronal excitability suggesting an excitatory role for NMU2 (Qiu et al., 2003) or 3) NMU1 activation inhibits both T-type and L-type Ca 2+ channels, suggesting an inhibitory role of NMU1 (Zhang et al., 2010; Wang et al., 2011) . Whether the biphasic response induced by the higher dose of NMU is a result of activation of two pharmacologically distinct NMU This article has not been copyedited and formatted. The final version may differ from this version. Our study demonstrates that NMU injection into the RVLM dose-dependently increases respiratory drive as indicated by an increase in PNamp and T E , and a decrease in T I . The RVLM is a functionally heterogeneous region with cardiovascular and respiratory (Bötzinger and pre-Bötzinger) regions intermingled (Pilowsky et al., 1990; Kanjhan et al., 1995; Pilowsky et al., 2009 ). This close relationship, and synaptic input from respiratory neurons to RVLM neurons (Sun et al., 1997) , along with close appositions between bulbospinal tyrosine hydroxylase immunoreactive neurons of the C1 cell group and boutons from identified
Bötzinger neurons (Sun et al., 1994 ) suggest a possible site of action for the known interactions between the two systems and a possible explanation for the effects of NMU on respiration observed in this study.
RVLM presympathetic neurons receive a direct input from respiratory neurons (Sun et al., 1997) and their discharge is synchronous with different phases of PNA (Haselton and Guyenet, 1989; Miyawaki et al., 1995; Miyawaki et al., 1996; Pilowsky et al., 1996) . It is also reported that at baseline, SSNA has two distinct respiratory related peaks whereas LSNA has only one peak, i.e., during PI-period (Miyawaki et al., 2002) . The findings here are consistent with such earlier studies. Following NMU injection in the RVLM, I-peak of LSNA became obvious with a clear increase in the AUC. The AUC of I-peak of SSNA is potentiated in the excitatory phase of the NMU response in the RVLM, but in the inhibitory phase the Ipeak of both SSNA and LSNA are reduced. On the other hand, the AUC of the PI-peak of both SSNA and LSNA is reduced at excitatory as well as inhibitory phase of NMU effect. A likely explanation for this finding is that NMU modulates RVLM neurons differentially, This article has not been copyedited and formatted. The final version may differ from this version. receiving input from inspiratory and expiratory neurons of the respiratory column, either presynaptically or post-synaptically.
RVLM neurons receive information from myelinated and/or unmyelinated somatic afferent neurons, integrate the information and relay the efferent signal to different sympathetic beds with at least two identifiable excitatory peaks in SSNA and LSNA (Sato and Schmidt, 1973 ).
An interesting finding of this study is that both the sympathoexcitatory peaks of SSNA and LSNA are attenuated by the higher dose of NMU at its excitatory, as well as its inhibitory phase. It is noteworthy that a significant inhibition of the somatosympathetic reflex was seen in both SSNA and LSNA where the ongoing activity was bidirectionally affected by NMU injection in the RVLM. Therefore, the selective inhibition of the somatosympathetic reflex cannot simply be related to the baseline shift following NMU injection. This inhibition at both excitatory and inhibitory phases of NMU response suggests an effect on the axon terminals or interneurons involved in the afferent limb of the somatosympathetic reflex, rather than a direct effect on RVLM neurons. RVLM neurons are activated, directly and indirectly, by hypoxia resulting in sympathoexcitatory, pressor and tachycardiac responses, along with an increase in PNA in vagotomized rats (Guyenet, 2000) . The inhibition of all cardiovascular and respiratory responses to hypoxia at the higher dose of NMU injection suggests a pre-and/or postsynaptic role on cardiovascular and/or intermingled respiratory neurons in the RVLM.
Activation of central chemoreceptors influences presympathetic RVLM neurons and increases sympathetic outflow via their effects on central respiratory network or independent of it through retrotrapezoid nucleus (RTN) (Guyenet et al., 2010) . To date, it remains unclear whether or not RTN neurons form monosynaptic, polysynaptic or both types of connection with RVLM neurons. The mechanisms by which NMU inhibit sympathoexcitatory and phrenic response to hypercapnia at both excitatory and inhibitory phases of its response is likely to be complicated, and the nature of the receptors involved in the responses are yet to be revealed.
This article has not been copyedited and formatted. The final version may differ from this version. Sympathetic outflow to the adrenal gland (SSNA) is regulated differently to the outflow targeting skeletal muscle (LSNA) by the presympathetic RVLM neurons as well as by the baroreceptors, chemoreceptors and somatic receptors (Dampney, 1994; Scislo et al., 1998; Pilowsky et al., 2009 ) . Here we found that the excitatory response observed in LSNA following administration of NMU, is significantly greater than that seen in SSNA.
Directionally gain for SSNA (error bars are omitted for clarity -see Table 1 ). C: Average lumbar sympathetic baroreflex function curves generated for data before (control) or after NMU (100 pmol, n=5) injection. Trace at right represents baroreflex gain for LSNA (error bars are omitted for clarity -see Table 1 ). Figure 6 . Effect of bilateral microinjection of neuromedin U (NMU) in rostral ventrolateral medulla on the cardiovascular and respiratory responses to hypoxia with 100% N 2 for 12-14s.
A: Experimental recording of hypoxic episodes at control period and after phosphate buffered saline (PBS) or NMU injection. B: Grouped data of peak effects on cardiovascular (mean arterial pressure (MAP), heart rate (HR), splanchnic sympathetic nerve activity (SSNA) and lumbar SNA (LSNA)) and respiratory function (phrenic nerve amplitude (PNamp) and phrenic nerve frequency (PNf)) after injection of PBS and NMU (100 pmol, n=5) in response to brief hypoxia. Values are expressed as mean ± SE. *** P < 0.001, ** P < 0.01, * P < 0.05 compared with control. bpm, beats per minute for HR or bursts per minute for PNf. 
